Chemoinformaics analysis of Teresantalol
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 9 |
Exact Molecular Weight | 152.12 | nRing | 4 |
Solubility: LogS | -2.396 | nHRing | 0 |
Solubility: LogP | 1.968 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.606 |
Synth | 5.379 |
Natural Product Likeliness | 2.779 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.471 |
MDCK | 0.0000276 |
BBB | 0.965 |
PPB | 0.574644 |
VDSS | 1.005 |
FU | 0.482337 |
CYP1A2-inh | 0.321 |
CYP1A2-sub | 0.461 |
CYP2c19-inh | 0.132 |
CYP2c19-sub | 0.861 |
CYP2c9-inh | 0.142 |
CYP2c9-sub | 0.442 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.461 |
CYP3a4-inh | 0.055 |
CYP3a4-sub | 0.273 |
CL | 14.961 |
T12 | 0.265 |
hERG | 0.017 |
Ames | 0.014 |
ROA | 0.099 |
SkinSen | 0.179 |
Carcinogencity | 0.103 |
EI | 0.906 |
Respiratory | 0.781 |
NR-Aromatase | 0.016 |
Antiviral | No |
Prediction | 0.934743 |